ShiraTronics, Inc. is focused on developing innovative neuromodulation therapies aimed at alleviating the debilitating effects of chronic migraines. Their primary technology involves a migraine-specific device that is implanted beneath the skin, which delivers continuous stimulation to specific nerves associated with migraine symptoms. This approach is designed to interrupt and potentially prevent the occurrence of chronic migraine attacks, offering a new avenue of relief for individuals who have not found success with traditional medication options.

The company emphasizes the importance of improving the quality of life for those suffering from chronic migraines, recognizing the profound impact this condition can have on daily activities and overall well-being. By leveraging neuromodulation, ShiraTronics aims to provide hope and effective solutions for patients, particularly as the condition can worsen over time for some individuals. Their commitment to clinical investigation underscores the investigational nature of their device, which is currently limited to research use under federal regulations.

United States

ShiraTronics is a forward-thinking medtech startup committed to revolutionizing the field of migraine medicine with our minimally invasive neuromodulation system. Our mission? To transform the lives of those facing Chronic Migraine by reducing headache days and restoring quality of life.

ShiraTronics, Inc.

Company Details